Sara Samimi is a Dermatology physician affiliated with University of Pennsylvania. OpenAlex indexes 56 publications with 704 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3400 Spruce St
Philadelphia, PA 191044238
Telephone
215-662-2737Registry record last updated 2 Sept 2015.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20243 payments
- Medtronic, Inc.Program year20231 payment
- SANOFI-AVENTIS U.S. LLCProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
24.9%Retinoid12.7%Acitretin100%Part D<11 patientsCorticosteroid12.1%Triamcinolone Acetonide100%Part D≥50 patientsCancer & immunology
24.9%Retinoid10.7%Bexarotene100%Part D<11 patientsInterferon gamma4.3%Actimmune100%Part D<11 patients+ 3 more classes in this area
Anti-infectives
17%Azole Antifungal11.2%Ketoconazole100%Part D≥39 patientsTetracycline-class Drug3.6%Doxycycline Hyclate100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Safety of Concurrent Systemic Therapy and Total Skin Electron Therapy in Cutaneous T-Cell Lymphoma
Clinical Lymphoma Myeloma & Leukemia
2026 - Cutaneous mantle cell lymphoma presenting as a diffuse morbilliform rash: A case report
SAGE Open Medical Case Reports
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Carl June, MD
University of Pennsylvania
Harold Feldman, MD
University of Pennsylvania
Howard Herrmann, MD
University of Pennsylvania
Robert Vonderheide, MD
University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”